Invention Grant
- Patent Title: Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors
- Patent Title (中): 吡啶并[5,4-D]嘧啶作为细胞增殖抑制剂
-
Application No.: US13062058Application Date: 2009-09-08
-
Publication No.: US08653087B2Publication Date: 2014-02-18
- Inventor: Andreas Mantoulidis , Georg Dahmann , Peter Ettmayer , Christian Klein , Steffen Steurer , Irene Waizenegger , Stephan Karl Zahn
- Applicant: Andreas Mantoulidis , Georg Dahmann , Peter Ettmayer , Christian Klein , Steffen Steurer , Irene Waizenegger , Stephan Karl Zahn
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Mary-Ellen M. Devlin
- Priority: EP08163897 20080908
- International Application: PCT/EP2009/061656 WO 20090908
- International Announcement: WO2010/026262 WO 20100311
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/00
![Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors](/abs-image/US/2014/02/18/US08653087B2/abs.jpg.150x150.jpg)
Abstract:
The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, X1, X2, X3, L1 and L2 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or anomalous cell proliferation, and the use thereof in such a treatment.
Public/Granted literature
- US20120094975A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS Public/Granted day:2012-04-19
Information query
IPC分类: